Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VYGR
VYGR logo

VYGR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Voyager Therapeutics Inc (VYGR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.800
1 Day change
3.26%
52 Week Range
5.550
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

VYGR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a short-term rebound in price, but the broader technical trend is still bearish, there are no fresh news catalysts, no strong proprietary buy signal, and the company lacks clear recent financial support in the data provided. For an impatient investor who does not want to wait for a better entry, this is still not an attractive buy today.

Technical Analysis

VYGR is trading at 3.835 with a recent 3.94% gain, but the chart structure remains weak. MACD histogram is -0.0347 and still below zero, RSI_6 at 50.83 is neutral, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. That indicates the stock is still in a downtrend despite the current bounce. Key levels: pivot 3.887, resistance at 4.307 and 4.567, support at 3.467 and 3.207. The stock trend model suggests a near-term mixed setup, with a possible 1.4% gain over the next week and 5.79% over the next month, but this does not override the bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment looks strongly bullish on the surface because puts are extremely light versus calls. Open interest put-call ratio of 0.05 and option volume put-call ratio of 0.01 both suggest traders are heavily favoring calls. However, the implied volatility is very high at 389.6, which signals elevated speculative activity rather than clean institutional conviction. Overall, options data is bullish, but it looks more like short-term speculation than durable long-term confidence.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
1

Positive Catalysts

  • Bullish options positioning is the main positive signal, with very low put-call ratios indicating call-heavy sentiment. The stock also has a small recent price uptick, and the modeled stock trend suggests possible short-term and monthly upside if momentum continues. The absence of negative news in the last week removes an immediate headline overhang.

Neutral/Negative Catalysts

  • No news in the recent week means there is no fresh catalyst driving sustained upside. Technicals are still bearish, with MACD below zero and moving averages stacked negatively. Hedge funds and insiders are neutral, so there is no meaningful buying signal from smart money or management. No recent congress trading data is available. Financial snapshot data is missing, so there is no clear recent earnings-based catalyst to support a long-term buy case.

Financial Performance

Latest quarter financials are not available because the financial snapshot returned an error, so there is no usable revenue or earnings trend to assess. Based on the provided data alone, there is no confirmed latest-quarter growth evidence to support a long-term accumulation decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no recent Wall Street upgrade/downgrade trend to support the stock. From the available information, Wall Street pros appear neutral at best: there is no clear bullish consensus signal, no strong insider or hedge fund buying, and no recent catalyst. The main pro is the very bullish options sentiment; the main con is the weak technical setup and lack of fundamental confirmation.

Wall Street analysts forecast VYGR stock price to rise
7 Analyst Rating
Wall Street analysts forecast VYGR stock price to rise
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 3.680
sliders
Low
8
Averages
13.2
High
25
Current: 3.680
sliders
Low
8
Averages
13.2
High
25
Morgan Stanley
Equal Weight
maintain
$25 -> $39
AI Analysis
2026-01-16
Reason
Morgan Stanley
Price Target
$25 -> $39
AI Analysis
2026-01-16
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Voyager Technologies to $39 from $25 and keeps an Equal Weight rating on the shares. In the Infrastructure market of Space Technology, the recently-introduced Space Superiority Executive Order should prove supportive overall, but investors are monitoring the extent to which the objectives outlined tangibly impact the opportunity set, the analyst says.
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$30 -> $25
2025-11-12
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$30 -> $25
2025-11-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Voyager Therapeutics to $25 from $30 and keeps a Buy rating on the shares. Voyager reported strong Q3 results, ending the quarter with $229M in cash and operational runway into 2028, while remaining eligible for up to $2.4B in partner milestones, the analyst tells investors in a research note. The company also advanced its NeuroShuttle non-viral delivery technology, with upcoming preclinical and trial data presentations expected to drive potential inflection points, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VYGR
Unlock Now

People Also Watch